The fight against breast cancer receives a crucial boost with advancements in diagnostic tools. Future Market Insights predicts the ESR1 Mutated Metastatic Breast Cancer Diagnostics Market to reach USD 185 million by 2033, reflecting a significant growth trajectory with a CAGR of 11% from 2023 to 2033. One of the key drivers of growth in …